Trial Profile
Lowering total immunosuppressive load in renal transplant recipients more than 12 months posttransplant-randomised withdrawal of mycophenolate mofetil (CellCept) or cyclosporine A (Sandimmun Neoral)
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Mycophenolate mofetil (Primary) ; Prednisolone
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 02 Dec 2005 New trial record.